{"schema_version":"secwatch.filing_event.v1","accession":"0000785161-24-000015","form_type":"8-K","ticker":"EHC","cik":"0000785161","company_name":"Encompass Health Corp","filed_at":"2024-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.913533+00:00","generated_at":"2026-06-05T00:14:53.950944+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Encompass Health reiterates FY2024 guidance at Barclays conference; no changes","bullets":["Company to present at Barclays Global Healthcare Conference on March 12, 2024, with CEO and CFO.","Reaffirms FY2024 guidance: net operating revenue $5,200M-$5,300M.","Adjusted EBITDA reaffirmed at $1,015M-$1,055M; adjusted EPS $3.77-$4.06.","Guidance unchanged from Feb 7 8-K and Feb 8 earnings call.","No new financial or operational updates disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0000785161-24-000015","json":"https://secwatch.observer/filing/0000785161-24-000015.json","markdown":"https://secwatch.observer/filing/0000785161-24-000015.md","text":"https://secwatch.observer/filing/0000785161-24-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/785161/000078516124000015/0000785161-24-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/785161/000078516124000015/ehc-20240311.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T00:14:53.950944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}